Sean F. Scanlan, SVP, Marketing at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 25,000 shares at $20.82 ($521K) on 2022-03-02, disclosed to the SEC on 2022-03-04.
Open-market sale of $520k TMCI by SVP, Marketing. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TMCI | SELL | 2023-03-10 | $12K | — | Filing → |
| TMCI | SELL | 2023-02-17 | $542K | — | Filing → |
| TMCI | SELL | 2023-01-13 | $639K | — | Filing → |